NDUFAB1 and cancer: BMP‐S6 was the only peptide that exhibited cancer cytotoxicity against K562 leukemic cells, consistent with previous studies.[5, 10] Accordingly, ALA‐A2 was designated the positive hit from in silico and in vitro ACP screening, and subjected to further validation.